Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial (2016)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM ; COGLIATI, BRUNO - FMVZ ; CARRILHO, FLAIR JOSÉ - FM ; WAITZBERG, DAN LINETZKY - FM
- Unidades: FM; FMVZ
- DOI: 10.1016/j.clnu.2015.05.001
- Subjects: HEPATITE; ÁCIDOS GRAXOS OMEGA 3; METABOLISMO DE GORDURA
- Keywords: alpha-linolenic acid; eicosapentaenoic acid; docosahexaenoic acid; flaxseed oil; nonalcoholic steatohepatitis
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Nutrition
- ISSN: 0261-5614
- Volume/Número/Paginação/Ano: v. 35, n. 3, p. 578-586, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NOGUEIRA, Monize Aydar et al. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition, v. 35, n. 3, p. 578-586, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2015.05.001. Acesso em: 13 fev. 2026. -
APA
Nogueira, M. A., Oliveira, C. P. M. S. de, Alves, V. A. F., Stefano, J. T., Rodrigues, L. S. dos R., Torrinhas, R. S. M. de M., et al. (2016). Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 35( 3), 578-586. doi:10.1016/j.clnu.2015.05.001 -
NLM
Nogueira MA, Oliveira CPMS de, Alves VAF, Stefano JT, Rodrigues LS dos R, Torrinhas RSM de M, Cogliati B, Barbeiro HV, Carrilho FJ, Waitzberg DL. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial [Internet]. Clinical Nutrition. 2016 ; 35( 3): 578-586.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.clnu.2015.05.001 -
Vancouver
Nogueira MA, Oliveira CPMS de, Alves VAF, Stefano JT, Rodrigues LS dos R, Torrinhas RSM de M, Cogliati B, Barbeiro HV, Carrilho FJ, Waitzberg DL. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial [Internet]. Clinical Nutrition. 2016 ; 35( 3): 578-586.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.clnu.2015.05.001 - Omega-3 fatty acids improve proteomic and lipidomic markers of endoplasmic reticulum (ER) stress and mito-chondrial dysfunction in a randomized controlled trial in subjects with Nonalcoholic Steatohepatitis
- Experimental models of liver fibrosis
- Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
- The combination of probiotics and prebiotics supplementation improves lipid metabolism, NAFLD and obesity in ob/ob mice
- Survivin expression patterns could reflect different roles in hepatocarcinogenesis, especially in non-alcoholic fatty liver disease-related hepatocellular carcinoma [Carta]
- Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
- Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
- P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC
- S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
- Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH - Proteomic and lipidomic insight
Informações sobre o DOI: 10.1016/j.clnu.2015.05.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
